Tanke Biosciences Corporation
TNBI · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $509 | $764 | $764 | $223 |
| - Cash | $37 | $38 | $0 | $0 |
| + Debt | $140 | $140 | $140 | $150 |
| Enterprise Value | $612 | $866 | $904 | $373 |
| Revenue | $8 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $8 | -$1 | -$1 | -$0 |
| % Margin | 93% | – | – | – |
| EBITDA | -$63 | -$90 | -$43 | -$22 |
| % Margin | -742.4% | – | – | – |
| Net Income | -$66 | -$99 | -$58 | -$23 |
| % Margin | -781.1% | – | – | – |
| EPS Diluted | -0.003 | -0.004 | -0.002 | -0.001 |
| % Growth | 33.3% | -69.6% | -130% | – |
| Operating Cash Flow | -$1 | -$5 | -$41 | $21 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$5 | -$41 | $21 |